Why the study?
Accurate assessment of LDL-C is important for treatment recommendations, but traditional calculation via the Friedewald equation has limitations compared with beta-quantification.
Do Friedewald, Martin-Hopkins, and NIH equation 2 methods accurately calculate LDL-C compared to beta-quantification in patients from pooled alirocumab trials?
Do Friedewald, Martin-Hopkins, and NIH equation 2 methods accurately calculate LDL-C compared to beta-quantification in patients from pooled alirocumab trials?
All three LDL-C calculation methods (Friedewald, Martin-Hopkins, NIH equation 2) are highly correlated with beta-quantification and can guide treatment decisions, though NIH equation 2 is most accurate when triglycerides are elevated.
Answers are grounded in this paper and cite their sources.
May support calculated LDL-C monitoring in alirocumab patients; leaves open prospective validation against clinical outcomes.
Accurate assessment of LDL-C levels is important, as they are often used for treatment recommendations. For many years, plasma LDL-C levels were calculated using the Friedewald equation, but there are limitations to this method compared with direct measurement via beta-quantification (BQ). Here, we assessed differences between the Friedewald, Martin-Hopkins, and NIH equation 2 methods of calculating LDL-C and the "gold standard" BQ method using pooled phase 3 data with alirocumab. All randomized patients were included irrespective of the treatment arm (n = 6,122). We compared pairs of LDL-C values (n = 17,077) determined by each equation and BQ. We found that BQ-derived LDL-C values ranged from 1 to 397 mg/dl (mean 90.68 mg/dl). There were strong correlations between Friedewald-calculated, Martin-Hopkins-calculated, and NIH equation 2-calculated LDL-C with BQ-determined LDL-C values (Pearson's correlation coefficient = 0.985, 0.981, and 0.985, respectively). Importantly, for BQ-derived LDL-C values ≥70 mg/dl, only 3.2%, 1.4%, and 1.8% of Friedewald-calculated, Martin-Hopkins-calculated, and NIH equation 2-calculated values were <70 mg/dl, respectively. When triglyceride (TG) levels were <150 mg/dl, differences between calculated and BQ-derived LDL-C values were minimal, regardless of the LDL-C level (<40, <55, or <70 mg/dl). However, when TG levels were >150 mg/dl, NIH equation 2 provided greater accuracy than Friedewald or Martin-Hopkins. When TGs were >250 mg/dl, inaccuracies were seen with all three methods, although NIH equation 2 remained the most accurate. In conclusion, LDL-C calculated by any of the three methods can guide treatment decisions for most patients, including those treated with proprotein convertase subtilisin/kexin type 9 inhibitors.
No takes yet. Share an insight, caveat, or question.
Ginsberg et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: